9th Annual IBA World Life Sciences Conference
31 May - 2 Jun 2023
Session information
Plenary session seven - Criminal considerations for corporate counsel
Friday 2 June (1120 - 1230)
Description
A life sciences company in the crosshairs of a government investigation faces wide variability in the penalties that can be brought against it and any responsible individuals within the company. Learn from government and in-house lawyers across the globe about the risk of criminal liability for regulatory violations. The panel will provide a comparison of the framework used in different countries for making prosecutorial decisions, and the compliance considerations that companies should consider minimising potential criminal exposure.
Session / Workshop Chair(s)
| Raj Pai | Sidley Austin, Washington, District of Columbia, USA |
| Anne Walsh | Hyman Phelps & McNamara PC, Washington, District of Columbia, USA; Vice Chair, Healthcare and Life Sciences Law Committee |
Speakers
| Martin Gantzhorn | Gorrissen Federspiel, Copenhagen, Denmark; European Regional Forum Liaison Officer, Healthcare and Life Sciences Law Committee |
| Ross Goldstein | US Department of Justice, Washington, District of Columbia, USA |
| Kathy Martin-Weis | former Acting Director, US FDA, Office of Criminal Investigations, Washington, District of Columbia, USA |